ENTITY
Sirnaomics

Sirnaomics (2257 HK)

30
Analysis
Health CareUnited States
Sirnaomics Ltd. operates as a clinical-stage RNA therapeutics biopharmaceutical company. The Company's products includes oncology, fibrosis-related diseases as well as antiviral and cardiometabolic diseases. Sirnaomics conducts businesses in USA and China.
more
bullishSirnaomics
15 Jan 2024 22:59Broker

Sirnaomics (2257 HK) – A Differentiated Biotech Company in RNAi Therapeutics

Two well-verified proprietary RNAi delivery platforms. Sirnaomics is a clinical-stage RNA therapeutics company with a strong presence in both Asia...

Logo
260 Views
Share
10 Nov 2024 09:27

China Healthcare Weekly (Nov.10)-Biotech Model Validation, CNPGC Need to Fulfill Commitment to Taiji

Out-licensing early-stage pipelines is the worst option. China Biotech at a critical point in verifying business models. CNPGC has other methods to...

Logo
311 Views
Share
02 Oct 2024 11:30

Hong Kong Connect Flows (Sep): Weak Inflows Ex-Alibaba

We noted 12 months of inflows for Southbound connect stocks and highlighted inflows into Alibaba, Kuaishou, Anta, HKEx, China Resource Land, China...

Logo
254 Views
Share
bullishCPMC Holdings
18 Aug 2024 10:00

HSCI Index Rebalance: 38 Adds, 29 Deletes & Changes to Southbound Stock Connect

There are 38 adds and 29 deletes for the HSCI at the September rebalance to take the number of index constituents up to 518. There will be a lot of...

Logo
485 Views
Share
03 Jul 2024 06:30

HSCI Index Rebalance Preview and Stock Connect: Potential Changes in September

There could be nearly 80 adds/deletes for the HSCI in September. That will trigger changes to the Southbound Stock Connect list and increase flows...

Logo
551 Views
Share
x